Last reviewed · How we verify

NCT05587946

The Effect of Virtual Reality Application Used During Endoscopy on Pain, Anxiety and Vital Signs: A Mixed Methods Study

Status unknown NA Last updated 3 November 2023
What this trial tests

NA trial testing Experimental group in Patient Relations, Nurse in 80 participants. Status unknown.

Timeline
15 January 2022
Primary endpoint
1 November 2023
1 November 2023

Quick facts

Lead sponsorİBRAHİM NAS
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposesupportive care
Enrollment80
Start date15 January 2022
Primary completion1 November 2023
Estimated completion1 November 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

İBRAHİM NAS

Who can join

18 and older, any sex, with Patient Relations, Nurse or Nurse's Role. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, the effect of virtual reality application used during upper gastrointestinal endoscopy on pain, anxiety and vital signs will be investigated. The research will be conducted as a mixed methods research including quantitative and qualitative methods. The exploratory sequence mixed design model, one of the mixed method designs, will be used in the research.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Experimental group

Trials testing the same drug.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05587946.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing